Search research articles
Contact Us
Filters
Showing results (41-50 of 92) with videos related to
Page
of 10
Sort By:
Arthritis and Rheumatism
|
July 27, 2006
Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus
Melanie J Harrison, Lisa D Ravdin, Michael D Lockshin
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 9, 2020
Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy
Elena Gkrouzman, Medha Barbhaiya, Doruk Erkan, et al.
Arthritis and Rheumatism
|
May 27, 2006
Journal policies on authorship and disclosures
Patricia P Katz, Edward H Yelin, Michael D Lockshin
Arthritis and Rheumatism
|
June 2, 2006
Journal policies on authorship and disclosures
Patricia P Katz, Edward H Yelin, Michael D Lockshin
JAMA
|
February 11, 2010
Clinical trial registration and publication of randomized controlled trials
Michael D Lockshin, Patricia P Katz, Edward H Yelin
Annals of the Rheumatic Diseases
|
March 6, 2007
Assessment of the 2006 revised antiphospholipid syndrome classification criteria
Mala Kaul, Doruk Erkan, Lisa Sammaritano, et al.
The Journal of Rheumatology
|
April 13, 2002
Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations
Doruk Erkan, Evan Leibowitz, Jessica Berman, et al.
Arthritis and Rheumatism
|
December 2, 2009
The child, grown, becomes independent
Patricia P Katz, Edward H Yelin, Michael D Lockshin
Arthritis and Rheumatism
|
November 6, 2012
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome
Doruk Erkan, JoAnn Vega, Glendalee Ramón, et al.
The Journal of Rheumatology
|
January 5, 2005
Interferon induced digital artery vasculitis
Wouter J M Derksen, Doruk Erkan, Hollis G Potter, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 92) with videos related to
Sort By:
Page
of 10
Arthritis and Rheumatism
|
July 27, 2006
Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus
Melanie J Harrison, Lisa D Ravdin, Michael D Lockshin
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 9, 2020
Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy
Elena Gkrouzman, Medha Barbhaiya, Doruk Erkan, et al.
Arthritis and Rheumatism
|
May 27, 2006
Journal policies on authorship and disclosures
Patricia P Katz, Edward H Yelin, Michael D Lockshin
Arthritis and Rheumatism
|
June 2, 2006
Journal policies on authorship and disclosures
Patricia P Katz, Edward H Yelin, Michael D Lockshin
JAMA
|
February 11, 2010
Clinical trial registration and publication of randomized controlled trials
Michael D Lockshin, Patricia P Katz, Edward H Yelin
Annals of the Rheumatic Diseases
|
March 6, 2007
Assessment of the 2006 revised antiphospholipid syndrome classification criteria
Mala Kaul, Doruk Erkan, Lisa Sammaritano, et al.
The Journal of Rheumatology
|
April 13, 2002
Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations
Doruk Erkan, Evan Leibowitz, Jessica Berman, et al.
Arthritis and Rheumatism
|
December 2, 2009
The child, grown, becomes independent
Patricia P Katz, Edward H Yelin, Michael D Lockshin
Arthritis and Rheumatism
|
November 6, 2012
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome
Doruk Erkan, JoAnn Vega, Glendalee Ramón, et al.
The Journal of Rheumatology
|
January 5, 2005
Interferon induced digital artery vasculitis
Wouter J M Derksen, Doruk Erkan, Hollis G Potter, et al.
Page
of 10